Rowatanal is commonly used to provide symptomatic support during episodes of uncomplicated haemorrhoids (piles), both internal and external. This product is applied across domains where additional symptomatic support is needed and is relevant in conditions characterized by periods of heightened symptoms such as localized pain, persistent itching (pruritus), and burning sensation. This support contributes to easing the overall symptom load, helping the patient cope more steadily with symptom fluctuations and supporting general well-being during symptomatic phases.

It is applied across domains where additional symptomatic support is needed, and may be relevant in clinical settings marked by increased discomfort or tension. It is commonly used in scenarios where additional management of discomfort is required, such as following certain daily activities, and may assist with maintaining functional stability when symptoms interfere with routine activities.

“The product is commonly used to provide supportive relief when symptoms become more noticeable, contributing to improved comfort during symptomatic periods.”

This product is commonly used to help address symptom clusters that may become intense or disruptive, specifically where symptoms are driven by localized surface distress and sensitivity. It is relevant for easing the impact of disruptive symptom manifestations by providing short-term symptomatic assistance.

Quick Fact: Relief for Anorectal Discomfort

This medication is relevant for easing the impact of disruptive symptom manifestations by providing short-term symptomatic assistance.

Regulatory References

1. Summary of Product Characteristics (SPC) for Rowatanal Cream

The population eligibility for Rowatanal is strictly defined by regulatory labeling, detailing the specific groups who can and cannot use the product.

Absolute Contraindication: The medicine is formally contraindicated for individuals with a known allergy or hypersensitivity to any of its active substances, including Bismuth Subgallate, Zinc Oxide, or Levomenthol, as well as any of the product's excipients.

The official profile establishes eligibility for Adults and the Elderly. Furthermore, eligibility for use requires mandatory professional consultation if the individual is experiencing rectal bleeding or if the symptoms of the underlying condition persist or worsen after application. These limitations ensure adherence to official label instructions.

Interactions with other medicines and products

The official regulatory documentation for Rowatanal Cream, a multi-component topical anorectal preparation, specifies that there are no known interactions with other medicinal products or other forms of interaction.

This interaction profile is consistent with a product formulated for topical, localized use, where the systemic absorption of its active ingredients—Bismuth Subgallate, Calcium Carbonate, Levomenthol, and Zinc Sulfate—is expected to be minimal. Consequently, the regulatory profile does not formally document any specific pharmacokinetic (PK) or pharmacodynamic (PD) interactions that would typically be associated with systemically administered drugs.

Official Regulatory Interaction Status

The overall regulatory position means no formally classified contraindications, timing-based restrictions, or required dose adjustments related to drug interactions are officially documented for Rowatanal. The patient information leaflet universally advises individuals to inform their doctor or pharmacist of all other medications being taken.

Rowatanal is a combination product whose pharmacodynamic effect is mediated by the local actions of its three active components on perianal tissue. Bismuth subgallate exerts an astringent action via the precipitation of proteins on the superficial layers of the rectal mucosa and submucosa. This protein-binding interaction forms a protective physical barrier over the targeted tissue, restricting the movement of fluid and cellular components into the local extracellular space. Zinc oxide functions via a similar mechanism, exhibiting mild astringent and protective properties through topical application, creating a physical coating on the affected epithelium. This mechanical action modifies the tissue's surface dynamics. Menthol acts as an agonist at the Transient Receptor Potential Melastatin 8 (TRPM8) cold receptor, a non-selective cation channel predominantly expressed in sensory nerve terminals. TRPM8 activation initiates a nerve signal that is distinct from the signal transmitted through C-fibres, resulting in a localized sensation of coolness. Furthermore, menthol displays vascular effects through vasodilation upon application to the skin, increasing local cutaneous blood flow. Collectively, these actions induce localized epithelial modifications and sensory signal modulation at the site of application.

Rowatanal cream is intended for rectal and perianal use only and should not be taken orally. It is indicated as an adjunct in the symptomatic relief of uncomplicated hemorrhoids and anal irritation.

Administration and Dosage

The following instructions are generally for adults and the elderly. Always follow the specific advice of a healthcare professional or the instructions provided with the product.

Important Considerations

• Duration of Use: Treatment should continue for a few days after the initial signs of symptom improvement are observed to ensure the condition is controlled.
• Applicator Care: The internal applicator nozzle must be thoroughly cleaned with hot detergent solution after every application to maintain hygiene.
• When to Consult a Doctor: Seek immediate medical advice if your hemorrhoids are bleeding, if the condition persists, or if symptoms worsen despite using the cream. Rectal bleeding is always an indication to consult a doctor.
• Precautions: Avoid contact with the eyes.

Research Evidence / Overview of Studies for Rowatanal

The research base for Rowatanal, a multi-component topical preparation, includes regulatory summaries and clinical studies examining its individual ingredients and similar combinations. This overview summarizes the structure of the available evidence, focusing on what has been studied and what remains uncertain, without providing any guidance on use or expected outcomes.

Evidence Base for Uncomplicated Haemorrhoids

Research related to the components of this preparation, or similar astringent and protectant combinations, includes data from short-term Randomized Controlled Trials (RCTs). This research was used in research exploring how symptoms change over time in adults with lower-grade, uncomplicated hemorrhoids. Researchers monitored patient-reported outcomes describing perceived discomfort, such as the severity of localized pain, pruritus (itching), and burning sensation.

Short-term trials explored patient-reported measurements of these acute symptoms over defined time intervals. Findings describe patterns observed in the studies. The inclusion of these components is based on their established physical properties, such as astringency. Research highlights changes measured during episodes where symptoms become more noticeable, contributing to the broader evidence landscape for topical symptomatic relief.

However, follow-up durations were limited, meaning long-term effects are not fully established regarding sustained comfort or the recurrence of symptoms. Comparative evidence is lacking for the full multi-component formulation directly against other active topical treatments.

Research Gaps and Areas of Uncertainty

The research available has several research limitation frames: evidence quality varies across studies, and sample sizes were modest in some of the trials involving multi-component preparations. Furthermore, findings were mixed or inconsistent regarding certain measured symptoms. Comparative evidence is lacking to fully establish the profile of this combination product against other topical hemorrhoid treatments. The existing evidence primarily provides insight into outcomes capturing phases of heightened symptom activity but does not determine whether an individual will respond similarly over extended periods.

Key Studies & References

1. Summary of Product Characteristics (SPC) - Rowatanal Cream and Suppositories (Regulatory/Dossier Information)
2. Levomenthol: Analgesic and Antipruritic Properties (Component Review)
3. FDA Monograph on Anorectal Drug Products for Over-the-Counter Human Use; Final Rule (Astringent/Protectant Components)

Common questions about Rowatanal (FAQ)

Q: Is Rowatanal available over the counter?

A: Rowatanal cream is generally listed as a Non-Prescription or Over-The-Counter (OTC) medicine in many regions. However, the prescription status and availability may vary depending on the specific country's regulatory rules.

Q: How quickly should I expect Rowatanal to start working?

A: Official product information notes that the active ingredient Menthol is included to relieve intense itching and burning. This suggests that the localized cooling and soothing effect is likely to be noticeable soon after application.

Q: What does Rowatanal feel like when you apply it?

A: According to the product information, it is common for users to experience a transient, or temporary, cooling sensation immediately after the cream is applied. This sensation is related to the action of the Menthol ingredient.

Q: What are the most common side effects people report with Rowatanal?

A: The most common local sensation is a transient cooling feeling upon application. Other documented adverse reactions reported rarely or very rarely include localized irritation and sensitivity (allergic) reactions.

Q: Is it normal to feel itchier after first using Rowatanal?

A: Official information mentions that local irritation is a rare, possible side effect. If new or worsening itching (pruritus) occurs or persists after initial use, it is important to consult a healthcare professional.

Q: Does Rowatanal lose its effectiveness over time if used regularly?

A: The product information cautions that prolonged use may increase the risk of developing sensitization to its components. Sensitization is when the body develops an allergic response to the product over time. The product information does not document a loss of effectiveness (tolerance).

Q: Does Rowatanal contain any local anesthetic?

A: Rowatanal contains Levomenthol, an active ingredient that provides a localized cooling sensation and a mild analgesic (pain-relieving) effect. However, the regulatory documents do not classify the product as containing a typical 'local anesthetic' like lidocaine or pramoxine.

Q: Can Rowatanal be used for conditions other than hemorrhoids?

A: The product is officially indicated for the symptomatic relief of uncomplicated hemorrhoids and anal irritation. This also includes symptoms such as pruritus (itching) and irritation around the back passage.

Q: Is it okay to use Rowatanal if I have sensitive skin?

A: The cream contains excipients like wool fat and parahydroxybenzoates, which are noted in the product warnings. These ingredients are documented as potentially causing local skin reactions, such as contact dermatitis or allergic reactions.

Q: Does Rowatanal contain petroleum jelly or similar base ingredients?

A: According to the list of excipients (non-active ingredients) in the product information, the cream does not contain petroleum jelly. Its base ingredients include hard paraffin, wool fat, and glycerol.

Q: Are there any known interactions between Rowatanal and blood thinners?

A: Official regulatory documentation states that there are no known interactions with other medicinal products. This is consistent with a product designed for localized topical use where systemic absorption is minimal.

Q: Is it normal for Rowatanal to have a distinct smell?

A: Yes, it is normal. The product contains Levomenthol as an active substance, which has a distinct and recognizable menthol odor.

Q: Do you need a prescription for Rowatanal suppositories?

A: While the cream is commonly available over-the-counter in many regions, the prescription status for the suppository form can vary by country. To determine the status in a specific area, one should check the local regulatory classification or consult a pharmacist.

Q: Are there any natural ingredients in Rowatanal?

A: One of the active ingredients, Levomenthol, is derived from natural sources, although it is used as a purified chemical substance in the medicine. The other active components, Zinc Oxide and Bismuth Subgallate, are mineral-based compounds.

Q: Do many people experience allergic reactions to Rowatanal?

A: Official post-marketing surveillance data indicates that sensitivity reactions (allergic responses) are documented as occurring Very Rarely. Individuals with a known hypersensitivity or allergy to any component of Rowatanal are advised in the product literature not to use the medication.

Q: Will Rowatanal stain clothing?

A: The product contains Bismuth Subgallate. Because the product contains Bismuth Subgallate, and related products may cause discoloration, there is a possibility of staining.

Q: Can I use Rowatanal if I'm taking herbal supplements?

A: The regulatory text specifies that no substance interactions are documented, including with food, alcohol, or supplements. This is based on the product's localized, topical action.

Q: Are there any long-term side effects associated with regular Rowatanal use?

A: The most significant long-term warning in the product information is that prolonged use may increase the risk of developing sensitization (an allergic reaction) to one or more of its components.

Q: Is there scientific evidence supporting the use of Rowatanal?

A: Studies and official information indicate that the research base includes data from short-term Randomized Controlled Trials (RCTs). These studies were used to explore how symptoms change over time and confirm the established physical properties, such as the astringent effect of the ingredients.

Q: Can older adults use Rowatanal safely?

A: The official product documentation explicitly lists the product as being permitted for use by Adults and the Elderly.

Q: Why do some people use Rowatanal for anal fissures?

A: While the primary indication is for hemorrhoids, the product is also indicated for the relief of symptoms such as anal irritation and pruritus (itching) around the back passage. These are common symptoms that may also be associated with anal fissures.

How to Store and Dispose of Rowatanal?

Regulatory documentation defines specific rules for the storage and disposal of Rowatanal cream to ensure product stability and safety.

Storage Requirements

Rowatanal cream must not be stored above 25 C to comply with the mandated stability conditions for its three-year shelf life. To prevent accidental exposure, the medicine must be kept out of the sight and reach of children, as required by the patient information labeling.

Disposal Instructions

To ensure proper handling of pharmaceutical waste, the official instructions require the user to consult a pharmacist for guidance on how to dispose of any expired or unused Rowatanal cream.